Clin2
NCT07262645Possibly a fitRecruiting

Light therapy for mild Alzheimer's disease

Alzheimer s Disease

Part of Brain & nervous system clinical trials.

This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
320 people
Ages
50 years to 85 years
Study type
Interventional

Who can take part

  • Age between 50 and 85 years old
  • Have a diagnosis of mild to moderate Alzheimer's disease with evidence of brain amyloid (a protein linked to Alzheimer's)
  • Memory loss for at least 12 months
  • Score between 15 and 26 on a memory test (adjusted for education)
  • Have a caregiver or study partner who can accompany you to daily treatment sessions
  • No other major medical or psychiatric conditions that could affect the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06836180Not yet recruiting· Early Phase 1
Light therapy for mild to moderate Alzheimer's disease

This study tests a light therapy that shines near-infrared light on the head to see if it can improve memory and thinking in people with mild to moderate Alzheimer's disease. It is an early-stage trial, so the main goal is to check safety and see if the treatment shows promise.

Beijing, Beijing Municipality
NCT06992804Recruiting· Early Phase 1
Light therapy and lecanemab for mild Alzheimer's

This trial tests whether a special near-infrared light device, combined with the medication lecanemab, can help people with mild Alzheimer's disease. It aims to see if the light therapy can slow down memory loss and improve daily function.

Beijing
NCT07835399Recruiting
Light therapy for mild cognitive impairment and mild Alzheimer's disease

This trial tests if shining a special light through the scalp and nose can help people with mild memory or thinking problems. It aims to slow down memory decline and improve daily life.

Beijing
NCT07230158Not yet recruiting
Electrical brain stimulation for early Alzheimer's disease

This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.

Beijing, Beijing Municipality
NCT06618807Recruiting
Infrared light for memory loss in mild cognitive impairment

This study tests whether shining a gentle infrared light on the head can help people with mild memory loss (MCI) improve their thinking and memory. It is designed for those who have mild cognitive impairment due to early Alzheimer's disease.

Toronto, Ontario
NCT05260177Recruiting
40 Hz light therapy for mild to moderate Alzheimer’s

This study tests whether a non-invasive 40 Hz light therapy system can help people with early Alzheimer’s. You’ll likely use the device at home and wear a small activity monitor, while doing memory and thinking tests.

Roskilde

Hear when a new Alzheimer s Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.